InsiderTrades

Form 4 for QDEL QuidelOrtho Corp

Accepted 2022-06-01 00:00:00 ET · period of report 2022-05-27 · accession 0000899243-22-020498 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-06-01 2022-05-27 QDEL WIDDER KENNETH J Dir A - Grant — +18.7K 18.7K New —
DM 2022-06-01 2022-05-27 QDEL WIDDER KENNETH J Dir A - Grant $0.00 +24.9K 7,021 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-05-27 A A 18,684 — 18,684 D — — (F1) Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.
2 Derivative Restricted Stock Units 2022-05-27 A A 512 $0.00 512 D — · — to — 512 Common Stock (F4) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F6) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.
3 Derivative Restricted Stock Units 2022-05-27 A A 153 $0.00 153 D — · — to — 153 Common Stock (F4) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F6) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.
4 Derivative Non-Qualified Stock Options 2022-05-27 A A 3,333 $0.00 3,333 D $27.91 · — to 2024-11-17 3,333 Common Stock (F3) Vested in full.
5 Derivative Non-Qualified Stock Options 2022-05-27 A A 7,021 $0.00 7,021 D $22.86 · — to 2025-05-05 7,021 Common Stock (F3) Vested in full.
6 Derivative Restricted Stock Units 2022-05-27 A A 98 $0.00 98 D — · — to — 98 Common Stock (F4) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F6) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.
7 Derivative Non-Qualified Stock Options 2022-05-27 A A 5,065 $0.00 5,065 D $24.80 · — to 2027-05-16 5,065 Common Stock (F3) Vested in full.
8 Derivative Restricted Stock Units 2022-05-27 A A 1,050 $0.00 1,050 D — · — to — 1,050 Common Stock (F4) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F6) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.
9 Derivative Restricted Stock Units 2022-05-27 A A 315 $0.00 315 D — · — to — 315 Common Stock (F4) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F6) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.
10 Derivative Restricted Stock Units 2022-05-27 A A 328 $0.00 328 D — · — to — 328 Common Stock (F4) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F6) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.
11 Derivative Non-Qualified Stock Options 2022-05-27 A A 7,021 $0.00 7,021 D $15.74 · — to 2026-05-17 7,021 Common Stock (F3) Vested in full.